Divalproex Sodium Tablet, Delayed Release
Product Images NDC 50090-7763

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 50090-7763). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Divalproex Sodium De Figure 1)

Structure (Divalproex Sodium De Figure 1)
FDA Label Image

Figure1 (Divalproex Sodium De Figure 2)

Figure1 (Divalproex Sodium De Figure 2)
FDA Label Image

Figure2 (Divalproex Sodium De Figure 3)

Figure2 (Divalproex Sodium De Figure 3)
FDA Label Image

Figure3 (Divalproex Sodium De Figure 4)

Figure3 (Divalproex Sodium De Figure 4)
FDA Label Image

Figure4 (Divalproex Sodium De Figure 5)

Figure4 (Divalproex Sodium De Figure 5)
FDA Label Image

Label Image (Lbl500907763)

Label Image (Lbl500907763)
This is a description for a medication called BVALPROEX SODIUM, USP. It comes in a 250 mg delayed-release formulation with a pack containing 30 tablets. The storage instructions advise keeping it at 68-77 degrees Fahrenheit. The product number is 610A-0.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.